Informative value of Hemoccult® test according to the number of positive slides in mass screening of colorectal cancer;Valeur informationnelle du test Hemoccult® selon le nombre de fenetres positives dans le depistage du cancer colorectal

Bulletin du Cancer

Volumn 85, Issue 12, 1998, Pages 1055-1059

  Tazi, Mohammed Adnane ^a   Faivre, Jean ^a   Lejeune, Catherine ^a   Dassonville, Frédéric ^a   Benhamiche, Anne Marie ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Colorectal cancer; Hemoccult test; Mass screening; Positive predictive value; Positive slides

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OCCULT BLOOD TEST; PREDICTION; ADENOMA; ANALYTICAL EQUIPMENT; COLORECTAL TUMOR; GASTROINTESTINAL HEMORRHAGE; METHODOLOGY; MIDDLE AGED; OCCULT BLOOD; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARD;

ADENOMA; AGED; COLORECTAL NEOPLASMS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0032416059     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. 1. Menegoz F, Black RJ, Arveux P, Magne V, Ferlay J, Buemi A, et al Cancer incidence and mortality in France in 1975-1995. Eur J Cancer Prev 1997 ; 6 : 442-66.
2. 2. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Esteve J. Survival of cancer patients in Europe. The Eurocare study. IARC SCI Publ n° 132, IARC, Lyon, 1995.
3. 3. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomized study of screening for colorectal cancer with fecal occult blood test at Funen in Denmark. Lancet 1996; 348 : 1467-71.
4. 4. Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW, et al. Randomized controlled trial of faecal occult blood screening for colorectal cancer. Lancet 1996 ; 348 : 1472-7.
5. 5. Sommer T, Kronborg O. Possible causes of a positive Hemoccult-II test in a population screening for colorectal cancer. Eur J Cancer Prev 1996; 5: 181-7.
6. 6. Launoy G, Herbert C, Reaud JM, Thezee Y, Tichet J, Maurel J, et al. Huemoccult test properties according to type and number of positive slides in mass screening for colorectal cancer. Br J Cancer 1995 ; 72 : 1043-6.
7. 7. Macrae FA, St John DJB. Relationship between patterns of Weeding and hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 1982; 82: 891-8.
8. 8. Farrands PA, Hardcastle JD. Factors affecting compliance with screening for colorectal cancer. Community Med 1984 ; 6 : 12-9.
9. 9. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for faecal occult blood. N Engl Med 1993 ; 328 : 1365-71.
10. 10. Robinson MHE, Thomas WM, Pye G, Hardcastle JD, Mangham M. Is dietary restriction always necessary in Haemoccult screening for colorectal neoplasia? Eur J Surg Oncol 1993 ; 19 : 539-42.
11. 11. Tazi MA, Faivre J, Dassonville F, Lamour J, Milan C, Durand G. Participation in faecal occult blood screening for colorectal cancer in a well defined French population : results for five sceening rounds from 1988 to 1996. J AM Screening 1997 ; 4: 147-51.
12. 12. Dukes CE. The classification of cancer of the rectum. J Pathol 1932 ; 35 : 323-32.